{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T08:31:50Z","timestamp":1768897910501,"version":"3.49.0"},"reference-count":114,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2021,3,4]]},"DOI":"10.1080\/14656566.2020.1836159","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T10:00:00Z","timestamp":1602496800000},"page":"469-481","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Advances in pharmacotherapy for cardiac amyloidosis"],"prefix":"10.1080","volume":"22","author":[{"given":"R.","family":"Spoladore","sequence":"first","affiliation":[{"name":"Hypertrophic Cardiomyopathy Unit, IRCCS San Raffaele University Hospital, Milan, Italy"},{"name":"Clinical Cardiology Unit, IRCCS San Raffaele University Hospital, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7128-9911","authenticated-orcid":false,"given":"G.","family":"Falasconi","sequence":"additional","affiliation":[{"name":"Clinical Cardiology Unit, IRCCS San Raffaele University Hospital, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Marcatti","sequence":"additional","affiliation":[{"name":"Haematology Unit, IRCCS San Raffaele University Hospital, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Di Maio","sequence":"additional","affiliation":[{"name":"Clinical Cardiology Unit, IRCCS San Raffaele University Hospital, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5726-8396","authenticated-orcid":false,"given":"G.","family":"Fiore","sequence":"additional","affiliation":[{"name":"Clinical Cardiology Unit, IRCCS San Raffaele University Hospital, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Slavich","sequence":"additional","affiliation":[{"name":"Clinical Cardiology Unit, IRCCS San Raffaele University Hospital, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Margonato","sequence":"additional","affiliation":[{"name":"Clinical Cardiology Unit, IRCCS San Raffaele University Hospital, Milan, Italy"},{"name":"Vita-Salute San Raffaele University, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Turco","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Fragasso","sequence":"additional","affiliation":[{"name":"Clinical Cardiology Unit, IRCCS San Raffaele University Hospital, Milan, Italy"},{"name":"Heart Failure Unit, IRCCS San Raffaele University Hospital, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,10,31]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2019.12.034"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2016.1257986"},{"key":"cit0003","first-page":"105","volume":"71","author":"WHO-IUIS Nomenclature Sub-committee","year":"1993","journal-title":"Bull World Health Organ"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-413682"},{"key":"cit0005","first-page":"343","volume":"24","author":"Maleszewski JJ.","year":"2015","journal-title":"Cardiovasc"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.111.000364"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.06.053"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-02-767467"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv338"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1159\/000444206"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.06.033"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx589"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.5724"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.10.028"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-302353"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.113.001396"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.05.073"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2011.10.001"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.100"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199704243361702"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070484"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.10.3662"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-730978"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11627"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.8220"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-390930"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-388462"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2013.08.015"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-620302"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.03.593"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.645.645"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-771220"},{"key":"cit0033","unstructured":"Study of dexamethasone plus IXAZOMIB (MLN 9708) or physicians choice of treatment in relapsed or refractory systemic light chain (AL) amyloidosis. 2020 [cited 2020 May 10]. Available at: https:\/\/ClinicalTrials.gov\/show\/NCT01659658"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.236"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1126\/science.1244851"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199911183412102"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-032987"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-030544"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12973"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.163246"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-413161"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-04-710822"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-12-756528"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-763599"},{"key":"cit0045","unstructured":"Daratumumab for the treatment of patients with AL amyloidosis. 2020 [cited 2020 May 10]. Available at: https:\/\/ClinicalTrials.gov\/show\/NCT02841033"},{"key":"cit0046","unstructured":"Daratumumab therapy for patients with refractory or relapsed AL amyloidosis. 2020 [cited 2020 May 10]. Available at: https:\/\/ClinicalTrials.gov\/show\/NCT02816476"},{"key":"cit0047","unstructured":"A study to evaluate the efficacy and safety of daratumumab in combination with cyclophosphamide, bortezomib and dexamethasone (CyBorD) compared to CyBorD alone in newly diagnosed systemic amyloid light-chain (AL) amyloidosis. 2020 [cited 2020 May 10]. Available at: https:\/\/ClinicalTrials.gov\/show\/NCT03201965"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052686"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.6530"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.644.644"},{"issue":"1","key":"cit0051","first-page":"509","volume":"130","author":"Edwards CV","year":"2017","journal-title":"Blood"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-118464"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504942"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan3128"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23521"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318248df18"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1126\/science.1079589"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.26.15051"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.283815"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1080\/13506120600960882"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7133.2012.00303.x"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182661eb1"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-013-7051-7"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.113.000890"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805689"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12225"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1007\/s12265-013-9512-x"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2017.1357545"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8064-9"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8337-3"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1007\/s12265-015-9613-9"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2009.10.062"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029933"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.1437"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-012-0463-z"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-015-0826-3"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-089243"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-008-0649-6"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-010-0142-x"},{"key":"cit0080","unstructured":"A trial for the treatment of cardiac AL-amyloidosis with the green tea compound epigallocatechin-3-gallate (TAME-AL). 2020 [cited 2020 May 10]. Available at: https:\/\/ClinicalTrials.gov\/show\/NCT02015312"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1300761110"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.03.012"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.1.4.4"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-041217-010829"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716793"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio839"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1038\/nature03121"},{"key":"cit0088","unstructured":"Alnylam Pharmaceuticals Inc. Summary of product characteristics. European Medicines Agency, 2018. 2020 [cited 2020 May 10]. Available at: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/onpattro-epar-product-information_en.pdf"},{"key":"cit0089","unstructured":"Alnylam Pharmaceuticals Inc. Prescribing information for onpattro. 2020 [cited 2020 May 10]. Available at: http:\/\/www.alnylam.com\/wp-content\/uploads\/2018\/08\/ONPATTRO-Prescribing-"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1021\/mp200654g"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2016.1160882"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716153"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.035831"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2012.674075"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.738138"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2017.1293514"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2016.1148025"},{"key":"cit0098","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-0764com"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2008.05.005"},{"key":"cit0100","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-8-74"},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2012.678508"},{"key":"cit0102","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.26"},{"key":"cit0103","unstructured":"Doxycycline to upgrade organ response in light chain (AL) amyloidosis trial. 2020 [cited 2020 May 10]. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT02207556"},{"key":"cit0104","unstructured":"A trial of doxycycline vs. standard supportive therapy in newly-diagnosed cardiac al amyloidosis patients undergoing bortezomib-based therapy. 2020 [cited 2020 May 10]. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03474458"},{"key":"cit0105","first-page":"351","volume":"6","author":"Giancaterino S","year":"2020","journal-title":"J Am Coll Cardiol EP"},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2015.1028616"},{"key":"cit0107","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(84)80436-2"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.489187"},{"key":"cit0109","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2018.1449744"},{"key":"cit0110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.03.022"},{"key":"cit0111","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12308"},{"key":"cit0112","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9592.2001.01228.x"},{"key":"cit0113","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu506"},{"key":"cit0114","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2017.11.015"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2020.1836159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T09:44:10Z","timestamp":1620467050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2020.1836159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,31]]},"references-count":114,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,3,4]]}},"alternative-id":["10.1080\/14656566.2020.1836159"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2020.1836159","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,31]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-05-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}